Development of a Broadly Applicable Cas12a-Linked Beam Unlocking Reaction for Sensitive and Specific Detection of Respiratory Pathogens Including SARS-CoV-2

Authors:

Abstract
The outbreak of novel coronavirus SARS-CoV-2 has caused a worldwide threat to public health. COVID-19 patients with SARS-CoV-2 infection can develop clinical symptoms that are often confused with the infections of other respiratory pathogens. Sensitive and specific detection of SARS-CoV-2 with the ability to discriminate from other viruses is urgently needed for COVID-19 diagnosis. Herein, we streamlined a highly efficient CRISPR-Cas12a-based nucleic acid detection platform, termed Cas12a-linked beam unlocking reaction (CALIBURN). We show that CALIBURN could detect SARS-CoV-2 and other coronaviruses and influenza viruses with little cross-reactivity. Importantly, CALIBURN allowed accurate diagnosis of clinical samples with extremely low viral loads, which is a major obstacle for the clinical applications of existing CRISPR diagnostic platforms. When tested on the specimens from SARS-CoV-2-positive and negative donors, CALIBURN exhibited 73.0% positive and 19.0% presumptive positive rates and 100% specificity. Moreover, unlike existing CRISPR detection methods that were mainly restricted to respiratory specimens, CALIBURN displayed consistent performance across both respiratory and nonrespiratory specimens, suggesting its broad specimen compatibility. Finally, using a mouse model of SARS-CoV-2 infection, we demonstrated that CALIBURN allowed detection of coexisting pathogens without cross-reactivity from a single tissue specimen. Our results suggest that CALIBURN can serve as a versatile platform for the diagnosis of COVID-19 and other respiratory infectious diseases.
Funding Information
  • Guangdong Provincial Introduction of Innovative Research and Development Team (2016ZT06Y337)
  • Zhejiang University (2020XGZX011)
  • Ministry of Education of the People's Republic of China (19ykzd25)
  • Ministry of Science and Technology of the People's Republic of China (2018YFC1200100, 2018ZX10301403, 2020YFC0841400)
  • ShanghaiTech University (2019F0301-000-01)
  • National Natural Science Foundation of China (91853106)
  • Shanghai Shen Kang Hospital Development Center (SHDC12018102)
  • National Innovative Research Team of High-level Local Universities in Shanghai
  • Zhangjiang National Innovation Demonstration Zone (ZJ2020-ZD-004)
  • Cultivation Project of Shanghai Major Infectious Disease Research Base (20dz2210500)
  • Key Laboratory of Emergency Prevention, Diagnosis and Treatment of Respiratory Infectious Diseases (20dz2261100)
  • Shanghai Municipal Key Clinical Specialty (shslczdzk02202)
  • Shanghai Top-Priority Clinical Key Disciplines Construction Project (2017ZZ02014)

This publication has 48 references indexed in Scilit: